Blue Bees Therapeutics
Entity

  • Blue Bees Therapeutics

    Created in 2022
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    145

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    21 Rue Jean Rostand, 91400 Orsay, France

    Orsay

    France

  • Employees

    Scale: 2-10

    Estimated: 8

  • Engaged corporates

    2
    2 0

  • Added in Motherbase

    3 months, 3 weeks ago
Description
  • Value proposition

    Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer

    Blue Bees Therapeutics is a biotechnology company founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay.

    This technology allows to generate antibodies stimulating the anti-tumor immune response via a double cell receptor targeting coupled with heparan sulphate proteoglycans (HSPG).

    Immunothérapie, Immuno-oncologie, pharma, Biotech, Immunologie, Oncologie, Cancer, Médicament, and Drug

  • Original language

    Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer

    Blue Bees Therapeutics is a biotechnology company, founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay.

    This technology allows to generate antibodies stimulating the anti-tumor immune response via a double cell receptor targeting coupled with heparan sulphate proteoglycans (HSPG).

  • Welcome to Blue Bees Therapeutics

    Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer

    • https://www.bbtx.fr/
Corporate interactions BETA
Corporate TypeTweets Articles
Genopole
Genopole
Biotechnology, Biotechnology Research
Genopole
Biotechnology, Biotechnology Research 		Other

23 Jan 2023


SATT Paris-Saclay
SATT Paris-Saclay
Research, Startup accelerator & VC, Research Services
SATT Paris-Saclay
Research, Startup accelerator & VC, Research Services 		Other

11 Jul 2023


Similar entities
Last news
Show all articles
Social network dynamics